Trillium Asset Management LLC Has $27.13 Million Stock Position in Elevance Health, Inc. (NYSE:ELV)

Trillium Asset Management LLC lessened its position in Elevance Health, Inc. (NYSE:ELV - Free Report) by 26.8% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 73,534 shares of the company's stock after selling 26,985 shares during the period. Trillium Asset Management LLC's holdings in Elevance Health were worth $27,127,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in ELV. GSA Capital Partners LLP acquired a new stake in shares of Elevance Health in the 3rd quarter valued at $518,000. Claro Advisors LLC boosted its stake in shares of Elevance Health by 41.7% in the 3rd quarter. Claro Advisors LLC now owns 1,006 shares of the company's stock valued at $523,000 after purchasing an additional 296 shares in the last quarter. Quest Partners LLC boosted its stake in shares of Elevance Health by 201.6% in the 3rd quarter. Quest Partners LLC now owns 2,319 shares of the company's stock valued at $1,206,000 after purchasing an additional 1,550 shares in the last quarter. Fifth Third Wealth Advisors LLC boosted its stake in shares of Elevance Health by 1.8% in the 3rd quarter. Fifth Third Wealth Advisors LLC now owns 2,206 shares of the company's stock valued at $1,147,000 after purchasing an additional 39 shares in the last quarter. Finally, Banque Cantonale Vaudoise lifted its position in Elevance Health by 32.7% during the 3rd quarter. Banque Cantonale Vaudoise now owns 15,384 shares of the company's stock worth $8,000,000 after buying an additional 3,788 shares in the last quarter. Institutional investors and hedge funds own 89.24% of the company's stock.

Remove Ads

Insider Buying and Selling

In related news, CAO Ronald W. Penczek sold 443 shares of the stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $415.13, for a total transaction of $183,902.59. Following the completion of the sale, the chief accounting officer now directly owns 1,847 shares of the company's stock, valued at approximately $766,745.11. This represents a 19.34 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Charles Morgan Kendrick, Jr. sold 3,504 shares of the stock in a transaction that occurred on Wednesday, March 5th. The stock was sold at an average price of $396.30, for a total value of $1,388,635.20. Following the sale, the executive vice president now directly owns 10,116 shares of the company's stock, valued at approximately $4,008,970.80. The trade was a 25.73 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.35% of the stock is owned by company insiders.

Elevance Health Trading Down 1.6 %

Shares of ELV stock traded down $7.01 on Friday, reaching $427.27. The company had a trading volume of 3,034,683 shares, compared to its average volume of 1,320,784. The company has a current ratio of 1.45, a quick ratio of 1.50 and a debt-to-equity ratio of 0.71. The stock has a market cap of $97.14 billion, a PE ratio of 16.68, a PEG ratio of 1.18 and a beta of 0.86. The company has a 50-day moving average of $400.52 and a 200-day moving average of $425.32. Elevance Health, Inc. has a 12 month low of $362.21 and a 12 month high of $567.26.

Elevance Health (NYSE:ELV - Get Free Report) last announced its quarterly earnings results on Thursday, January 23rd. The company reported $3.84 EPS for the quarter, beating analysts' consensus estimates of $3.80 by $0.04. Elevance Health had a return on equity of 18.28% and a net margin of 3.38%. On average, equities analysts forecast that Elevance Health, Inc. will post 33.96 earnings per share for the current year.

Elevance Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 25th. Stockholders of record on Monday, March 10th will be paid a $1.71 dividend. The ex-dividend date is Monday, March 10th. This is a boost from Elevance Health's previous quarterly dividend of $1.63. This represents a $6.84 dividend on an annualized basis and a dividend yield of 1.60%. Elevance Health's dividend payout ratio is 26.71%.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on ELV. Cantor Fitzgerald reiterated an "overweight" rating and set a $485.00 price target on shares of Elevance Health in a research report on Friday, January 24th. Stephens downgraded shares of Elevance Health from an "overweight" rating to an "equal weight" rating and reduced their price target for the stock from $520.00 to $440.00 in a research report on Wednesday, January 22nd. Truist Financial reduced their price target on shares of Elevance Health from $520.00 to $480.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. StockNews.com upgraded shares of Elevance Health from a "hold" rating to a "buy" rating in a research report on Thursday. Finally, Barclays upped their price target on shares of Elevance Health from $501.00 to $512.00 and gave the stock an "overweight" rating in a research report on Friday, January 24th. Two investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Elevance Health presently has a consensus rating of "Moderate Buy" and a consensus target price of $519.81.

About Elevance Health

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.